CannabisNewsBreaks Archive - Page 84 of 217

TuesdayApr 28, 2020 11:03 am

CannabisNewsBreaks – Supreme Cannabis Company, Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 7ACRES Division Launches New Brand Extension

Supreme Cannabis Company’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 7ACRES division today announced that it has launched a new brand extension called 7ACRES Craft Collective. With a focus on high THC and remarkable quality, 7ACRES Craft Collective will launch small batches of craft cannabis that is hand selected by the experts at 7ACRES for individual provinces based on their cannabis preferences. The first strain launched under the new brand extension will be a Pink Kush that is grown and exclusively available in British Columbia. “We are excited to launch 7ACRES Craft Collective as a way to bring new and unique…

TuesdayApr 28, 2020 10:15 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Chosen as Headline Partner for PSYCH: The Psychedelics Symposium

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that it has been chosen as the Headline Partner for Prohibition Partners LIVE’s PSYCH: The Psychedelics Symposium (“PSYCH”). The psychedelics virtual conference, scheduled to take place June 22 - 23, 2020, will highlight the most recent developments in the psychedelic industry, hear from world-renowned speakers and engage with a network of industry-leading professionals. “The impact of COVID-19 has put greater emphasis on…

MondayApr 27, 2020 10:17 am

CannabisNewsBreaks – Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Appoints Proven Leader in Canadian CPG Sector, Beena Goldenberg, as President and CEO

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its board of directors (the “Board”) has named Beena Goldenberg, former CEO of Hain-Celestial Canada ("Hain Canada"), as the Company's president and chief executive officer, effective immediately. According to the update, Goldenberg succeeds Colin Moore who, as interim president and CEO since January 2020, took significant steps to reduce the Company's operating and overhead costs, expand its product offering across all market segments and accelerate its transition into a premium cannabis consumer packaged goods ("CPG") company. Moore will continue to serve as a director of the Company and…

MondayApr 27, 2020 9:48 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Update on Timing of Annual Filings

Plus Products (CSE: PLUS) (OTCQX: PLPRF) on Friday announced that, as a result of the COVID-19 pandemic, it will be relying on the coordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (“CSA“) on March 18, 2020. According to the update, Plus Products will rely on this relief with respect to the filing of its annual financial statements, management’s discussion and analysis, and related officer certificates for its financial year ended December 31, 2019. The Company will provide a further update concerning the exact timing…

FridayApr 24, 2020 11:55 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches New CBDRelief Brand Targeting Underserved Market Sector

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a California-based cannabis-products company, recently launched its PLUS CBDRelief brand. The new line of products is comprised of two high-CBD, low-THC gummies designed to address pain, stress and anxiety (http://cnw.fm/KL07j). An article discussing the company reads, “The product line currently includes two products: PLUS CBDRelief 9:1 Tropical Mango with 9 mg of CBD and 1 mg of THC per serving and PLUS CBDRelief 18:1 Tart Cherry with 18 mg of CBD and 1 mg of THC per serving. The PLUS CBDRelief cannabis-infused gummies are expected to be available statewide in coming weeks. . . .…

ThursdayApr 23, 2020 10:19 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Commences Trading on the OTCQB Venture Market

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares have graduated from the OTC Pink Open Market to the OTCQB Venture Market (the “OTCQB”), a U.S. trading platform operated by the OTC Markets Group. Effective immediately, Champignon Brands will commence trading on the OTCQB under the ticker symbol “SHRMF.” Champignon’s common shares will continue to trade under the ticker symbol “SHRM” on the Canadian Securities Exchange as…

ThursdayApr 23, 2020 10:10 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Notice of Allowance for New Patent, Issuance of Stock Options Under Equity Incentive Plan

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its receipt of a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for a new patent. According to the update, the new patent provides additional claims that protect the use of its DehydraTECH(TM) technology together with cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs, or vitamins in mix and serve beverage formats. This patent, with application number 16/497,920 under the title "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof," signifies another addition to Lexaria's first patent family, under…

WednesdayApr 22, 2020 11:59 am

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Announces Private Placement, Date for Release of Q4 Earnings

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Tuesday announced a non-brokered private placement for gross proceeds of C$20,000,000, with, at the company’s discretion, the ability to upsize the amount to an aggregate gross proceeds of C$25,000,000. According to the update, the company expects to use the proceeds of the Offering for general working capital purposes. “Despite the challenging capital markets environment, we are extremely fortunate to announce this financing and to have continued support from management and insiders who have been instrumental in Flowr’s founding, strategic direction and financing since inception,” Flowr’s CEO Vinay Tolia stated in the news…

WednesdayApr 22, 2020 9:25 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Research Partner Secures Steady Psilocybin Supply for Clinical Studies

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company that is advancing its clinical pipeline through its ongoing TBI/PTSD-focused preclinical studies at the University of Miami’s Miller School of Medicine, today announced that its research partner and lead investigator, Dr. Michael Hoffer, has obtained a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, Champignon’s wholly owned subsidiary, Tassili Life Sciences Corp., is conducting preclinical studies and eventual human clinical trials, with…

TuesdayApr 21, 2020 9:46 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application for DehydraTECH Technology in Delivery of Antiviral Drugs

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to the update, the technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS. "Lexaria's proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

CannabisNewsBreaks